Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Discover the key moments to adjust a zero based budget to ensure it aligns with your financial goals and maximizes savings.
18,819 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
A sharp spike in local impact fees in Manatee County jeopardizes Live Local housing projects as developers and lawmak...
A 69-year-old employee demonstrates a practical path to postponing required minimum distributions by remaining with h...
Micron’s blowout quarter ignited a rally that dwarfed many peers, but the broader memory-chip sector lifted a key ETF...
For the first time ever, Citi Wealth notes a surge in ultrawealthy U.S. clients seeking cross-border diversification ...
A former U.S. soccer player has built a $20 billion-a-year tech company and now credits relentless resilience over na...
PayPal has faced a long stretch of underperformance, leaving investors wondering if the stock is a true bargain or a ...
A deep dive into a sleeper AI infrastructure stock that could gain as data centers demand faster, cleaner connectivit...
Microsoft’s Satya Nadella signals a data-centric AI strategy, arguing buyers must reveal proprietary know-how to unlo...
An insider sale at AGCO raises questions about the agricultural machinery cycle. This article breaks down what what t...
Public disclosures show surprising activity in major names, but smart investing hinges on fundamentals, risk, and a d...
As the 2026 COLA rises to 2.8%, investors turn to steady income stocks that more than cover the gap. A trio of picks ...